Join us at the Psychedelic Therapeutics Conference, a focused scientific and industry conference bringing together researchers, clinicians, regulators, and industry leaders involved in the development of psychedelic-based therapies. The meeting covers clinical development, regulatory pathways, intellectual property, commercialization, and emerging data across mental health and neurological indications. It is particularly relevant for companies working with controlled substances and novel small-molecule therapeutics.